Evidence map›Paper›PMID 32690637›Full record

ArticleInfection and immunity2020

Differential Induction of Type I and III Interferons by

Adeline Peignier, Paul J Planet, Dane Parker

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.3field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Roles and Effects of Interferon Lambda Signaling in the Context of Bacterial Infections.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2023
    Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. The Role of Macrophages inFrontiers in immunology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Adeline PeignierDepartment of Pathology, Immunology and Laboratory Medicine, Center for Immunity and Inflammation, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
Paul J PlanetDivision of Pediatric Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Dane ParkerDepartment of Pathology, Immunology and Laboratory Medicine, Center for Immunity and Inflammation, Rutgers New Jersey Medical School, Newark, New Jersey, USA dane.parker@rutgers.edu.ORCID 0000-0001-7304-3392
Rutgers, The State University of New Jersey · USChildren's Hospital of Philadelphia · US

Funding

ROLE OF TYPE III INTERFERONS IN STAPHYLOCOCCUS AUREUS RESPIRATORY TRACT INFECTIONR01HL134870 · NHLBI · RBHS-NEW JERSEY MEDICAL SCHOOL · PI PARKER, DANE · 2017 to 2020
$1.8M
Bacterial Interference to Prevent Staphylococcus aureus InfectionR01AI137526 · NIAID · CHILDREN'S HOSP OF PHILADELPHIA · PI PLANET, PAUL J · 2018 to 2021
$1.7M
NHLBI NIH HHS R01 HL134870NIAID NIH HHS R01 AI137526
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAnti-Bacterial AgentsBacterial LoadBacterial ProteinsCells, CulturedCytokinesDrug Resistance, BacterialInterferon LambdaInterferon Type IInterleukinsLysostaphinMiceMicrobial Sensitivity TestsMutationPneumonia, StaphylococcalSignal TransductionAnti-Bacterial AgentsBacterial ProteinsCytokinesInterferon Lambdainterferon-lambda protein, mouseInterferon Type IInterleukinsLysostaphinVancomycinhost-pathogen interactionslungpneumoniaStaphylococcus aureustype III interferontype I interferonvancomycinVISA

Identifiers

PMID32690637
PMCPMC7504949
OpenAlexW3042915390

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.